Other risk factors for death were BMI (HR 0.91, P = 0.012), deceased donor (HR 2.00, P = 0.008), log AFP (HR 1.18, P = 0.007), systemic or radiotherapy versus locoregional therapy (HR 3.71, P < 0.001), viable tumor number (HR 1.06, P = 0.006), satellite nodule (HR 4.52, P < 0.001), and use of mTORi within 3 months (HR 0.25, P < 0.001). Here, AFP is linked to neoplasm.